67 (PB057) - Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
| Autor: | Dziadziuszko, R., Garralda Cabanas, E., Rojas, K., Chelstowska, M., Blaszkowska, M., Dudziak, R., Rzymski, T., Angelosanto, N., Littlewood, P., Nogai, H., Boni, V., Lugowska, I. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S23-S23 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect